[1]
|
Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro‐inflammatory cytokines
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.28913
|
|
|
[2]
|
Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro‐inflammatory cytokines
Journal of Cellular Physiology,
2019
DOI:10.1002/jcp.28913
|
|
|
[3]
|
Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2014.15.24.10705
|
|
|
[4]
|
Hesa-A Improves Clinical Outcome of Oral Carcinoma by Affecting p53 Gene Expression in vivo
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2015.16.10.4169
|
|
|
[5]
|
Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2015.16.16.6947
|
|
|
[6]
|
Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women
Molecular and Cellular Endocrinology,
2014
DOI:10.1016/j.mce.2013.09.030
|
|
|
[7]
|
Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
Asian Pacific Journal of Cancer Prevention,
2014
DOI:10.7314/APJCP.2014.15.15.6227
|
|
|
[8]
|
DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
Asian Pacific Journal of Cancer Prevention,
2014
DOI:10.7314/APJCP.2014.15.19.8377
|
|
|
[9]
|
New formulated "DOX-MTX-loaded Nanoparticles" Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities
Asian Pacific Journal of Cancer Prevention,
2014
DOI:10.7314/APJCP.2014.15.21.9355
|
|
|